Skip to content
Dose Brief
Menu
No. 7 on the board · Grade B+

Ondra Health review

A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.

Visit Ondra Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$93/mo
Tirzepatide
$166/mo
Coverage
All 50 states
Brand-name
Yes
On the trackerStableprice stable$93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.

The scorecard

Ondra Health scored on our six Brief Score factors. See the methodology.

Price Stability88/100
Supply Reliability86/100
Transparency88/100
Access Breadth90/100
Clinical Oversight88/100
Track Record82/100

What we like

  • $93 semaglutide is the lowest accredited nationwide line we track
  • Brand-name access alongside compounded
  • LegitScript-certified, all 50 states

The caveats

  • Very low pricing is unproven over time — watch for step-ups
  • Compounded track record still young
  • No oral route

The brief

Best for: Value-focused readers who refuse to trade accreditation or nationwide reach for a low price. A rare combination of a rock-bottom $93 semaglutide, brand-name access, LegitScript certification and all-50-state reach.

Ranked #7 of 25 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Ondra Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Ondra Health's site. Not medical advice; see our disclosure.

← Back to all rankings